|
About the Confirmatory Testing category -Please read before posting
|
|
0
|
556
|
August 13, 2021
|
|
Determining Low PPB Levels of Nitrite in Polymeric Excipients
|
|
0
|
110
|
September 10, 2024
|
|
N-nitroso-rivaroxaban amide
|
|
6
|
1258
|
August 29, 2024
|
|
Analytical procedure development and proposed established conditions: A case study of a mass spectrometry based NDSRI analytical procedure -Pub
|
|
17
|
1255
|
August 18, 2024
|
|
Nitrosamine testing on stability samples?
|
|
19
|
1484
|
July 26, 2024
|
|
Exploration and detection of nitrosamine impurity nitroso-STG-19 in sitagliptin tablets and API as well as nitrites in excipients by LC-MS/MS methods -Pub
|
|
0
|
218
|
July 25, 2024
|
|
Stability of resolution solution
|
|
1
|
200
|
July 24, 2024
|
|
Quantification of Nitrite in Excipients and Chemicals: A Versatile and Highly Sensitive Method Using Headspace Gas Chromatography Coupled to Mass Spectrometry -Pub
|
|
0
|
876
|
July 23, 2024
|
|
Novel LC-MSMS Method including for E&L of packaging materials
|
|
1
|
722
|
July 11, 2024
|
|
Parts per billion of nitrite in microcrystalline cellulose -Pub
|
|
3
|
1020
|
July 3, 2024
|
|
Nitrite in Pharmaceutical Manufacturing Water: Development of an Ultra-Sensitive Analytical Method, Typical Data, and Discussion of Potential Nitrosamine Formation in Drug Substance and Drug Product from Water
|
|
2
|
579
|
June 20, 2024
|
|
Method of Analysis for N nitroso Diclofenac and Quetiapine
|
|
11
|
1556
|
June 14, 2024
|
|
How to circumvent matrix effect in confirmatory testing
|
|
6
|
330
|
June 6, 2024
|
|
Formic acid-aided sample preparation method for sensitive and simultaneous analysis of eight nitrosamines in poorly-water soluble pharmaceutical drugs using liquid chromatography–ultraviolet detection
|
|
0
|
159
|
June 2, 2024
|
|
Nitrosamines: Mass Spectrometry-Based Analytical Procedures
|
|
5
|
2874
|
May 20, 2024
|
|
Challenges and winning strategies to develop an analytical method for Nitrosamines
|
|
0
|
644
|
May 19, 2024
|
|
Nitrosamine and NDSRIs conventional detection methods and other options
|
|
5
|
350
|
May 16, 2024
|
|
How to justify the absence of NDSRIs in finished product if the custom synthesis of the same NDSRIs is not possible?
|
|
1
|
637
|
May 13, 2024
|
|
Challenges in Confirmatory Testing for Nitrosamines potential presence Identified from Step 1 Risk Assessment
|
|
5
|
623
|
May 8, 2024
|
|
Safeguarding purity under pressure: detecting nitrosamine contamination
|
|
0
|
401
|
April 23, 2024
|
|
Nitroso amines quantification in drugs which are having MDD Value more than 10.0g/Day
|
|
2
|
377
|
March 20, 2024
|
|
🇪🇺 OMCL Network published NDSRIs Analytical Methods
|
|
1
|
1167
|
March 11, 2024
|
|
Simple and Practical Method for the Quantitative High-Sensitivity Analysis of N-Nitroso Duloxetine in Duloxetine Drug Products Utilizing LC-MS/MS
|
|
0
|
564
|
March 9, 2024
|
|
Anybody using Thermal Energy Analysis for Nitrosamine testing?
|
|
6
|
1042
|
February 27, 2024
|
|
GC-ECD as a method of detection for nitrosamines
|
|
0
|
274
|
February 26, 2024
|
|
New Validated LC-MS Method Development and Estimation of Nitrosamine impurities in Canaglifozin -Pub
|
|
0
|
682
|
February 16, 2024
|
|
Testig method for nitroso Ciprofloxacin
|
|
12
|
1343
|
February 16, 2024
|
|
NDSRIs standards (for confirmatory testing or ames/other tests)
|
|
15
|
1375
|
February 14, 2024
|
|
Analytical Challenge for detecting NDSRI in Ritonavir Tablets
|
|
8
|
528
|
February 12, 2024
|
|
LC/Q-TOF-MS-based structural characterization of enasidenib degradation products and establishment of a stability-indicating assay method: Insights into chemical stability -Pub
|
|
0
|
248
|
January 23, 2024
|